Dr. Daud Discusses the Current Status of Immunotherapy in Melanoma – OncLive
OncLive |
Dr. Daud Discusses the Current Status of Immunotherapy in Melanoma
OncLive Adil Daud, MD, clinical professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, at University of California, San Francisco, discusses the current status of immunotherapy in melanoma. Immunotherapy is at a very exciting point … |
